ADVERTISEMENTs
AIIMS, University of Liverpool collaborate for cancer research
An MoU was also signed between the two institutions in 2022
AIIMS-Delhi and University of Liverpool collaborate for research on head-neck cancer / image: University of Liverpool
The All India Institute of Medical Sciences (AIIMS), Delhi and University of Liverpool have joined hands to set up a collaborative centre for translational research in head-neck cancer (HNC).
The centre, which will be situated at the National Cancer Institute at AIIMS’ Jhajjar campus, will focus on research and education programmes to transform the care of HNC patients in the UK, India and globally, according to a statement by the University of Liverpool.
Both the institutes signed the Letter of Intent, committing to a major new UK-India initiative, in the presence of Mansukh L. Mandaviya, Minister for health and family welfare, Christina Scott, British Deputy High Commissioner to India, and directors of AIIMS and the National Cancer Institute.
The @AIIMS_NewDelhi inks agreement regarding collaboration with @LivUni for "AIIMS Liverpool Collaborative Centre For Translational Research in Head and Neck Cancer".
— Dr Mansukh Mandaviya (@mansukhmandviya) February 12, 2024
This will help in delivering cutting edge medical innovation & personalised cancer treatments. pic.twitter.com/oS3Ubb5Ym4
Giving more details about the partnership, Tim Jones, vice-chancellor of the university, said, “This initiative has been built upon a pre-existing collaboration and links between the Liverpool Head and Neck centre, the University of Liverpool and the head and neck cancer unit of AIIMS Delhi. A memorandum of understanding was signed between the two institutions in 2022.”
“I am extremely pleased to confirm the university’s full support and commitment to the creation and development of the centre,” he added.
Tariq Ali, pro-vice-chancellor for global engagements and partnerships of the university, remarked, “By working together, we will have a significant impact on people’s lives in both our countries and globally. This latest collaboration forms part of the University of Liverpool’s strategic ambitions to develop and invest in a range of important international partnerships,” he added.
HNC is the seventh most common cancer globally, accounting for more than 660,000 new cases and 325,000 deaths annually. There will be 2.1 million new cancer cases in India by 2040, an increase of 57.5 percent from the year 2020, according to a report by GLOBOCAN in 2020.
Moreover, one in nine Indians has a lifetime risk of developing cancer. Head-Neck Cancer (HNC), in particular, accounts for 30 percent of the all-cancer cases in the country.
Last September, AIIMS also signed a non-binding memorandum of understanding with a Munich-based university for collaborating in the field of medicine and life sciences.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
.jpg)
E Paper
ADVERTISEMENT
Video
.jpg)
.png)
.png)
.png)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login